SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the appointment of J. Wayne Cowens, M.D. as Chief Medical Officer. An industry veteran and clinical oncologist, Dr. Cowens will drive the development of the company’s pipeline of molecular diagnostic tests for cancer.
